Back to Search
Start Over
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.
- Source :
-
Leukemia [Leukemia] 2020 Oct; Vol. 34 (10), pp. 2815-2816. Date of Electronic Publication: 2020 Sep 02. - Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 34
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Editorial & Opinion
- Accession number :
- 32879427
- Full Text :
- https://doi.org/10.1038/s41375-020-01038-8